Mostrar el registro sencillo del ítem
dc.contributor.author
Martin, Maximiliano Emanuel
dc.contributor.author
Gaete, Laura
dc.contributor.author
Tetzlaff, Walter Francisco
dc.contributor.author
Ferraro, Maria Florencia
dc.contributor.author
Chiappe, Gladys Ethel
dc.contributor.author
Botta, Eliana Elizabeth
dc.contributor.author
Costa, Viviana Angélica
dc.contributor.author
Saez, Maria Soledad
dc.contributor.author
Lorenzon Gonzalez, María V.
dc.contributor.author
Palenque, Patricia
dc.contributor.author
Ballerini, Maria Gabriela
dc.contributor.author
Sorroche, Patricia Beatriz
dc.contributor.author
Boero, Laura
dc.contributor.author
Trifone, Liliana
dc.contributor.author
Brites, Fernando Daniel
dc.date.available
2022-05-13T17:58:42Z
dc.date.issued
2022-01-01
dc.identifier.citation
Martin, Maximiliano Emanuel; Gaete, Laura; Tetzlaff, Walter Francisco; Ferraro, Maria Florencia; Chiappe, Gladys Ethel; et al.; Vascular inflammation and impaired reverse cholesterol transport and lipid metabolism in obese children and adolescents; Elsevier; Nutrition, Metabolism and Cardiovascular Diseases; 32; 1; 1-1-2022; 1-11
dc.identifier.issn
0939-4753
dc.identifier.uri
http://hdl.handle.net/11336/157508
dc.description.abstract
Background and aims: Childhood obesity is associated to complications such as insulin resistance and dyslipidemia. High density lipoproteins (HDL) constitute the only lipoprotein fraction with ateroprotective properties. The aim of the present study was to analyze inflammatory markers, carbohydrate metabolism, lipid profile and HDL functionality in obese children and adolescents compared to healthy controls. Methods and results: Twenty obese children and adolescents (Body mass index z score >3.0) (9–15 years old) and 20 age and sex similar controls were included in the study. Triglyceride (TG), total cholesterol (TC), HDL-C, LDL-C, apolipoproteins (apo) A-I and B, glucose and insulin levels were quantified. Lipid indexes and HOMA-IR were calculated. Cholesterol efflux (CEC), lipoprotein associated phospholipase A2 (Lp-PLA2), lecithin-cholesterol acyl transferase (LCAT) and cholesteryl ester transfer protein, plus paraoxonase and arylesterase (ARE) activities were evaluated. Obese children and adolescents showed significantly higher TG [69 (45–95) vs 96 (76–121); p < 0.05], non-HDL-C [99 ± 34 vs 128 ± 26; p < 0.01], TC/HDL-C [2.8 ± 0.6 vs 4.7 ± 1.5; p < 0.01], TG/HDL-C [1.1 (1.0–1.8) vs 2,2 (1.4–3.2); p < 0.01], and HOMA-IR [1.5 (1.1–1.9) vs. 2.6 (2.0–4.5); p < 0.01] values, plus Lp-PLA2 activity [8.3 ± 1.9 vs 7.1 ± 1.7 umol/ml.h; p < 0,05] in addition to lower HDL-C [57 ± 10 vs 39 ± 9; p < 0.01], apo A-I [143 ± 25 vs 125 ± 19; p < 0.05], and CEC [6.4 (5.1–6.8) vs. 7.8 (5.7–9.5); p < 0.01] plus LCAT [12.6 ± 3.3 vs 18.7 ± 2.6; p < 0.05] and ARE [96 ± 19 vs. 110 ± 19; p < 0.05] activities. Lp-PLA2 activity correlated with LDL-C (r = 0.72,p < 0.01), non-HDL-C (r = 0.76,p < 0.01), and apo B (r = 0.60,p < 0.01). LCAT activity correlated with triglycerides (r = −0.78,p < 0.01), HDL-C (r = 0.64,p < 0.01), and apo A-I (r = 0.62, p < 0.05). ARE activity correlated with HDL-C (r = 0.32,p < 0.05) and apoA-I (r = 0.43,p < 0.01). CEC was negatively associated with BMI z-score (r = −0.36,p < 0.05), and triglycerides (r = −0.28,p < 0.05), and positively with LCAT activity (r = 0.65,p < 0.05). In multivariate analysis, BMI z-score was the only parameter significantly associated to CEC (r2 = 0.43, beta = −0.38, p < 0.05). Conclusion: The obese group showed alterations in carbohydrate and lipid metabolism, which were associated to the presence of vascular specific inflammation and impairment of HDL atheroprotective capacity. These children and adolescents would present qualitative alterations in their lipoproteins which would determine higher risk of suffering premature cardiovascular disease.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
OBESITY
dc.subject
HDL
dc.subject
REVERSE CHOLESTEROL TRANSPORT
dc.subject
CHILDREN
dc.subject.classification
Otras Ciencias de la Salud
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Vascular inflammation and impaired reverse cholesterol transport and lipid metabolism in obese children and adolescents
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2022-05-12T06:29:29Z
dc.identifier.eissn
1590-3729
dc.journal.volume
32
dc.journal.number
1
dc.journal.pagination
1-11
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Martin, Maximiliano Emanuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Biológica; Argentina
dc.description.fil
Fil: Gaete, Laura. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina
dc.description.fil
Fil: Tetzlaff, Walter Francisco. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Ferraro, Maria Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Chiappe, Gladys Ethel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Botta, Eliana Elizabeth. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Costa, Viviana Angélica. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina
dc.description.fil
Fil: Saez, Maria Soledad. Hospital Italiano; Argentina
dc.description.fil
Fil: Lorenzon Gonzalez, María V.. Hospital Italiano; Argentina
dc.description.fil
Fil: Palenque, Patricia. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina
dc.description.fil
Fil: Ballerini, Maria Gabriela. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Sorroche, Patricia Beatriz. Hospital Italiano; Argentina
dc.description.fil
Fil: Boero, Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Trifone, Liliana. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina
dc.description.fil
Fil: Brites, Fernando Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.journal.title
Nutrition, Metabolism and Cardiovascular Diseases
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.nmcd-journal.com/article/S0939-4753(21)00465-8/fulltext
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.numecd.2021.09.025
Archivos asociados